Cargando…
Application status and future prospects of the PDX model in lung cancer
Lung cancer is one of the most prevalent, fatal, and highly heterogeneous diseases that, seriously threaten human health. Lung cancer is primarily caused by the aberrant expression of multiple genes in the cells. Lung cancer treatment options include surgery, radiation, chemotherapy, targeted therap...
Autores principales: | Liu, Wei, Cui, Yishuang, Zheng, Xuan, Yu, Kunpeng, Sun, Guogui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080030/ https://www.ncbi.nlm.nih.gov/pubmed/37035154 http://dx.doi.org/10.3389/fonc.2023.1098581 |
Ejemplares similares
-
Identification of prognosis-related lncRNAs and cell validation in lung squamous cell carcinoma based on TCGA data
por: Cui, Yishuang, et al.
Publicado: (2023) -
Efficacy of radiomics model based on the concept of gross tumor volume and clinical target volume in predicting occult lymph node metastasis in non-small cell lung cancer
por: Zeng, Chao, et al.
Publicado: (2023) -
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer
por: De Angelis, Maria Laura, et al.
Publicado: (2022) -
Development and Validation of the Oxidative Stress Related lncRNAs for Prognosis in Esophageal Squamous Cell Carcinoma
por: Zheng, Xuan, et al.
Publicado: (2023) -
The possible molecular mechanism underlying the involvement of the variable shear factor QKI in the epithelial-mesenchymal transformation of oesophageal cancer
por: Cui, Yishuang, et al.
Publicado: (2023)